ADAG Competitors & Alternatives
Compare Adagene Inc with similar stocks in the same industry
Biotechnology
ADAG
Main Stock$3.63
Tradestie Score
52
Market Cap
$94.26M
Revenue Growth
73.3%
Analyst Upside
+195.9%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$27.92
|
$293.03M | - | 51 | Compare |
|
OMER
Omeros Corporation
|
$12.56
|
$281.75M | 10.4 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.58
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.84
|
$275.13M | - | 50 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$21.41
|
$269.08M | - | 55 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.52
|
$262.67M | - | 52 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$32.87
|
$256.54M | - | 55 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.22
|
$211.22M | - | 47 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.53
|
$202.58M | - | 60 | Compare |
More ADAG Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry